HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
ID: 354743Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354743

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-061.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of the Justice Community Overdose Innovation Network (JCOIN) Phase II Economic Research Resource Center (ERRC), aimed at addressing the overdose crisis among individuals with substance use disorders (SUD) within the criminal justice system. This initiative seeks applications to conduct research and economic analysis related to service delivery, implementation of interventions, and evaluation of costs in the context of the criminal legal system, emphasizing collaboration and capacity building among research hubs. The funding amount may total $800,000, with a maximum project period of five years, and applications are due by December 22, 2024. For further details, interested organizations can contact NIH Grants Information at grantsinfo@nih.gov or visit the announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-061.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DA-25-061-Full-Announcement.html
    RFA-DA-25-061.html
    The funding opportunity from the National Institutes of Health (NIH) aims to establish the Justice Community Overdose Innovation Network (JCOIN) Phase II Economic Research Resource Center (ERRC). This initiative addresses the intersection of criminal justice and healthcare systems to tackle the overdose crisis, particularly for individuals with substance use disorders (SUD). The NIH seeks applications to conduct research and support economic analysis related to service delivery, implementation of interventions, and evaluation of costs in the criminal legal context. The ERRC will facilitate collaboration among research hubs, engage in methodological research, and provide practitioner-focused tools and technical assistance. Four core activities include research support for JCOIN Hubs, conducting original economic research projects, developing practitioner-facing tools, and offering consultation services. Interested organizations can apply for funding that may total $800,000, with a maximum project period of five years, emphasizing collaboration, capacity building, and dissemination of findings to inform decision-making in service delivery for individuals at risk of overdose. The anticipated application due date is December 22, 2024, with further details and instructions available in the announcement.
    Similar Opportunities
    HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Community Engaged Research Resource Center (CERRC), aimed at addressing the overdose crisis among individuals involved in the criminal-legal system. This initiative seeks to engage various stakeholders in researching effective interventions for substance use disorders (SUD) and enhancing continuity of care between public health and public safety agencies, with a focus on community engagement and diversity, equity, and inclusion (DEI). The funding, capped at $750,000 per year, is available for projects that include engaging individuals with lived experience, creating public resources for community-engaged research, and conducting rapid turnaround research projects, with applications due by January 23, 2025. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-026.html.
    HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional), aimed at addressing substance use disorder (SUD) within the criminal-legal system. This initiative focuses on enhancing research and effective interventions for individuals at risk of overdose during their transition through various stages of the justice system, with an emphasis on increasing access to medication for opioid use disorder (MOUD). The program will support multi-site studies, conduct cost analyses, and develop resources for practitioners, with a total funding amount of $800,000 allocated for one award. Interested applicants must submit their proposals by January 22, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Clinical Research Hubs, which requires a UM1 clinical trial. This initiative aims to address the opioid overdose crisis by researching effective interventions for individuals with substance use disorders (SUD) within the criminal justice system, focusing on optimizing treatment and enhancing collaboration between justice and community health agencies. The program anticipates funding 8-10 awards, with a total budget of approximately $14 million over five years, and emphasizes the importance of stakeholder engagement and diverse perspectives in the research process. Interested applicants must submit their proposals by January 22, 2025, and can find more information at the provided NIH grants link or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis," aimed at supporting research that translates findings into practical solutions for addressing the overdose crisis. This initiative encourages applications from a diverse range of organizations, including educational institutions and nonprofits, with a focus on developing stigma-free, patient-centered systems for addiction recovery and improving the quality of addiction treatment services. The NIH plans to commit approximately $10 million to fund grants, with an expected award ceiling of $750,000 for up to 12 awards, and applications will be accepted starting February 20, 2025, with a closing date of March 20, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-077.html.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-054), aimed at supporting innovative research that bridges the gap between research findings and practical applications to combat the opioid overdose crisis. This initiative emphasizes the need for stigma-free, patient-centered care systems and focuses on understudied areas related to overdose prevention, requiring applicants to present preliminary data for significant projects within a maximum project period of five years and a budget of up to $750,000 in direct costs annually. The funding reflects a commitment to addressing health disparities and promoting effective addiction treatment and recovery solutions, with applications evaluated based on significance, innovation, feasibility, and stakeholder engagement. Interested applicants should note that the application deadline is March 20, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis" (RFA-DA-25-078), aimed at supporting research that transforms addiction treatment and care to combat the ongoing overdose crisis. This initiative encourages phased applications (R61/R33), where the R61 phase focuses on exploratory activities without the need for existing pilot data, while the R33 phase seeks to implement larger studies based on successful R61 milestones, emphasizing stigma-free and patient-centered approaches. With up to $10 million allocated for FY2026 and a maximum award period of six years, applicants must include a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity, and applications are to be submitted through Grants.gov by the closing date of March 20, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)" aimed at accelerating the development of medications for Substance Use Disorders (SUDs). This initiative encourages research applications for diverse preclinical and clinical projects that can expedite the FDA approval process for new treatments, addressing the significant public health need for effective therapies for conditions such as cocaine, methamphetamine, and cannabis use disorders. The program will provide cooperative agreements for projects lasting up to three years, with annual budgets capped at $5 million, and applications are accepted on a rolling basis with specific due dates for scientific merit review established throughout 2023 and 2024. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-202.html.
    NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering the P50 Research Center of Excellence Grant Program to support innovative research in substance use and addiction. This program aims to establish multidisciplinary research centers that not only advance scientific knowledge but also serve as national resources for education and outreach within the drug abuse research community. The initiative encourages applications that focus on integrated themes rather than incremental work, with a budget limit of $10 million over five years and a maximum of 25% of direct costs allocated to pilot projects. Interested applicants should note that the submission process requires adherence to specific guidelines, including a Plan for Enhancing Diverse Perspectives (PEDP), and key deadlines extend until November 18, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the HEAL Initiative funding opportunity titled "Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-053). This initiative aims to support research that translates findings into actionable practices to combat the ongoing overdose crisis in the U.S., with a focus on developing innovative, scalable, and equitable strategies for patient-centered care in addiction treatment. The funding mechanism allows for projects to span up to six years, divided into a two-year planning phase (R61) and a five-year implementation phase (R33), with an anticipated total funding of up to $15 million based on the quality of applications received. Interested applicants can find more details and submission guidelines at the provided link and should direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. The application deadline is March 20, 2025.